Reinaldo Diaz joined Watch Hill Partners as a Partner in November 2006. Before joining the firm, Mr. Diaz was co-founder and Managing Member of D&A Capital Management, LLC, a firm focused on asset management and on providing advisory services to companies in the Healthcare sector, particularly biopharmaceutical companies. From 1997 to 2001, D&A Capital structured and acted as private placement agent for transactions that provided more than $250 million to biopharmaceutical companies including Cephalon, Inc., Sugen, Inc. and Creative Biomolecules, Inc. D&A Capital, through affiliated entities, managed the Delta Opportunity Funds, a group of hedge funds with more than $100 million in assets under management at its peak. Mr. Diaz was Chief Investment Officer at Delta from inception to early 2006. Prior to forming D&A Capital in 1997, Mr. Diaz was Managing Director and Head of the Healthcare group at Schroder Wertheim & Co., Inc. In that capacity, he was responsible for establishing and developing Schroder Wertheim's investment banking presence in the Healthcare industry. In 1985, Mr. Diaz co-founded PaineWebber Development Corporation (“PWDC”) and in 1990 he became PWDC's president. PWDC provided financial advisory services to healthcare clients, managed more than $225 million of capital invested principally in the healthcare sector, and raised approximately $700 million to fund the development of novel biopharmaceutical and medical device products.

Mr. Diaz received his Bachelor of Arts degree from Harvard College and his M.B.A. from Harvard University Graduate School of Business. He is currently a Trustee of The Episcopal School in New York City.